The antibiotic is produced by Bacillus subtilis strains and exhibits broad spectrum activity. Mutant screening led to high productivity, permitting industrialization.

CAS press release, March 20, 2013

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny